MRVI CIK: 1823239

Maravai LifeSciences Holdings, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY23
FY24
FY24
FY24
FY25
FY23 – FY25

Assets

(positive)
Change from FY23 to FY25
billions USD
FY23:
0.70
FY24:
0.68
FY24:
0.68
FY24:
0.43
FY25:
0.30
(positive)
Change from FY23 to FY25
billions USD
FY23:
0.79
FY24:
0.76
FY24:
0.60
FY24:
0.58
FY25:
0.47
Total assets
Change from FY23 to FY25
billions USD
FY23:
1.49
FY24:
1.44
FY24:
1.28
FY24:
1.01
FY25:
0.77

Liabilities & Equity

(negative)
Change from FY23 to FY25
billions USD
FY23:
0.09
FY24:
0.07
FY24:
0.06
FY24:
0.06
FY25:
0.04
(negative)
Change from FY23 to FY25
billions USD
FY23:
0.61
FY24:
0.60
FY24:
0.60
FY24:
0.37
FY25:
0.35
(positive)
Change from FY23 to FY25
billions USD
FY23:
0.42
FY24:
0.43
FY24:
0.34
FY24:
0.33
FY25:
0.21

All amounts in billions USD Data source:SEC EDGAR